Theme: Advancements in management of Atherosclerosis

Atherosclerosis 2016

Atherosclerosis 2016

Conference series LLC invites you to attend the Annual Conference on Atherosclerosis and Clinical Cardiology to be held at July 11-12, 2016, Philadelphia, USA organized by Conference series LLC will bring together world-class professors, scientists and cardiologists to discuss strategies for disease remediation for heart in this cardiology conferenceCardiology meetings are diversified on topics like cardiology congressworld cardiology conferencecardiovascular conference, cardiac surgery conference.

Accreditation:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint provider ship of Peer Point Medical Education Institute and Conference Series, LLC.

Peer Point Medical Education Institute is accredited by the ACCME to provide continuing medical education for physicians.

Designation:

Peer Point Medical Education Institute designates the live format for this educational activity for a maximum of 10 AMA PRA Category 1 Credits™.

Physicians should only claim credit commensurate with the extent of their participation in the activity.

Annual Conference on Atherosclerosis and Clinical Cardiology is designed to provide diverse and current education that will keep medical professionals abreast of the issues affecting the prevention, diagnosis and treatment of Atherosclerosis.

Atherosclerosis is a disease in which plaque builds up inside arteries, blood vessels that carry oxygen-rich blood to heart and other parts of body. Plaque is made up of fat, cholesterol, calcium, and other substances found in the blood. Over time, plaque hardens and narrows arteries. This limits the flow of oxygen-rich blood to your organs and other parts of your body. Atherosclerosis can affect any artery in the body, including arteries in the heart, brain, arms, legs, pelvis, and kidneys. As a result, different diseases may develop based on which arteries are affected.

Conference series LLC Organizes 1000+ Global events  every year across the globe with support from 1000+ more scientific societies and Publishes 500+ Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members. The Cardiology Conferences 2016 have been designed with a wide spectrum.

The Atherosclerosis 2016 will be organized around the theme “Advancements in management of Atherosclerosis ".

Track 1: Atherosclerosis

Atherosclerosis sometimes called hardening of the arteries can slowly narrow and harden the arteries throughout the body. When atherosclerosis affects the arteries of the heart, it’s called coronary artery disease. Heart diseases, such as coronary heart disease, heart attack, high blood pressure are the leading cause of death for men and women. Most of these deaths are from heart attacks caused by sudden blood clots in the heart’s arteries.

Related Conferences:  Arrhythmia and Cardiac Surgery Meeting July 14-15, 2016 Brisbane, Australia; Cardiovascular Medicine Conference August 01-02, 2016 Manchester, UK; Global Cardiologists  Meeting July 18-20, 2016 Berlin, Germany; Echocardiography Conference July 18-19, 2016 Berlin, Germany; International Cardiac Conference September 14-15, 2016 Philadelphia, USA; World Cardiothoracic Meeting December 08-09, 2016 Philadelphia, USA. 19th Annual Update on Pediatric and Congenital Cardiovascular Disease February 24- 28, 2016, Orlando, USA; American Cardiology Congress 2016; ACC Annual Meeting 2016; American Cardiology Congress 2016; European Cardiology Congress August 27-31, 2016 Rome, Italy; 21st World Congress on Heart Disease, July 30-August 01, 2016, Boston, MA, USA; 5th Annual Innovations in Valve and Structural Heart disease 2016, Feb 15-17 One Baha Mar Boulevard, Nassau, Bahamas; International Conference on Cardiology and Cardiac surgery April 04-06, 2016, Dubai, UAE
 

Track 2: Clinical Cardiology

Clinical Cardiology is a specialty of internal medicine. Clinical cardiology is the area where patients are access to specialized inpatient and outpatient heart care and long-term management of their conditions. The clinical cardiology focuses on the diagnosis, medical management (use of medicines), and prevention of cardiovascular disease. Cardiologists are specialized in diagnosing and treating diseases or conditions of the heart and blood vessels and the cardiovascular system.

Related Conferences: Arrhythmias Congress July 14-15, 2016, Brisbane, Australia; Cardio Vascular Medicine Conference August 01-02, 2016, Manchester, UK; International Cardiac Conference September 14-15, 2016, Philadelphia, USA; Echocardiography Conference June 06-07, 2016 London, UK; World Congress of Cardiology and Cardiovascular Health Mexico City, Mexico June 04-07, 2016; American Cardiology Association, 2016; 19th Annual Update on Paediatric and Congenital Cardiovascular Disease February 24- 28, 2016, Orlando; European Society of Cardiology Congress 27-31 August 2016 Rome, Italy; European Cardiology Congress, 2016; 4th International Conference on Prehypertension, Hypertension & Cardio Metabolic Syndrome, March 03-06, 2016, Venice, Italy; Cardiac Society of Cardiology, 2016
 

Track 3: Coronary Artery Atherosclerosis

Coronary artery disease (CAD), also called heart disease, results from a complex process known as atherosclerosis (commonly called "hardening of the arteries"). In atherosclerosis, fatty deposits (plaques) of cholesterol and other cellular waste products build up in the inner linings of the heart’s arteries. This causes blockage of arteries and prevents oxygen-rich blood from reaching the heart (ischemia). 

Related Conferences: Arrhythmia and Cardiac Surgery Meeting July 14-15, 2016 Brisbane, Australia; Cardiovascular Medicine Conference August 01-02, 2016 Manchester, UK; Global Cardiologists  Meeting July 18-20, 2016 Berlin, Germany; Echocardiography Conference July 18-19, 2016 Berlin, Germany; International Cardiac Conference September 14-15, 2016 Philadelphia, USA; World Cardiothoracic Meeting December 08-09, 2016 Philadelphia, USA. 19th Annual Update on Pediatric and Congenital Cardiovascular Disease February 24- 28, 2016, Orlando, USA; American Cardiology Congress 2016; ACC Annual Meeting 2016; American Cardiology Congress 2016; European Cardiology Congress August 27-31, 2016 Rome, Italy; 21st World Congress on Heart Disease, July 30-August 01, 2016, Boston, MA, USA; 5th Annual Innovations in Valve and Structural Heart disease 2016, Feb 15-17 One Baha Mar Boulevard, Nassau, Bahamas; International Conference on Cardiology and Cardiac surgery April 04-06, 2016, Dubai, UAE
 

 

Track 4: Atherosclerosis Risk Factors

Many factors lead to the risk for atherosclerosis. Some risks can be prevented, while others cannot. Atherosclerosis is a slow, progressive disease that may begin as early as childhood. Although the exact cause is unknown, it may start with damage, injury or hardening of the inner layer of an artery. The common causes for hardening of the arteries are high cholesterol, fat, aging, smoking, high blood pressure etc.

Related Conferences: Arrhythmias Congress July 14-15, 2016 Brisbane, Australia; Cardio Vascular Medicine Conference August 01-02, 2016 Manchester, UK; International Cardiac Conference September 14-15, 2016 Philadelphia, USA; Echocardiography Conference June 06-07, 2016 London, UK; World Congress of Cardiology and Cardiovascular Health Mexico City, Mexico June 04-07, 2016; American Cardiology Association, 2016; 19th Annual Update on Paediatric and Congenital Cardiovascular Disease February 24- 28, 2016, Orlando; European Society of Cardiology Congress 27-31 August 2016 Rome, Italy; European Cardiology Congress, 2016; 4th International Conference on Prehypertension, Hypertension & Cardio Metabolic Syndrome, March 03-06, 2016, Venice, Italy; Cardiac Society of Cardiology, 2016
 

Track 5: Clinical Manifestations of Atherosclerosis

Atherosclerosis does not usually produce symptoms until blood circulation becomes restricted or blocked, leading to cardiovascular disease (CVD). The type of cardiovascular disease and its associated symptoms depends on where the blockage occurs. Conditions caused by atherosclerosis include peripheral arterial disease, angina, aneurysm, heart attack and stroke.

Related Conferences: Arrhythmias Congress July 14-15, 2016 Brisbane, Australia; Cardio Vascular Medicine Conference August 01-02, 2016 Manchester, UK; International Cardiac Conference September 14-15, 2016 Philadelphia, USA; Echocardiography Conference June 06-07, 2016 London, UK; World Congress of Cardiology and Cardiovascular Health Mexico City, Mexico June 04-07, 2016; American Cardiology Association, 2016; ACC Annual Meetings, 2016; 19th Annual Update on Paediatric and Congenital Cardiovascular Disease February 24- 28, 2016, Orlando; European Society of Cardiology Congress 27-31 August 2016 Rome, Italy; European Cardiology Congress, 2016; 4th International Conference on Prehypertension, Hypertension & Cardio Metabolic Syndrome, March 03-06, 2016, Venice, Italy; Cardiac Society of Cardiology, 2016
 

Track 6: Interpretations of Atherosclerosis

Atherosclerosis interpretations are the most common cause of deaths. The one test that can directly show blocked arteries is called angiography. Angiography is an "invasive" test. As atherosclerosis does not cause symptoms until cardiovascular disease occurs, screening allows treatment to be given to reduce the risk of cardiovascular disease developing.

Related Conferences: Arrhythmia and Cardiac Surgery Meeting July 14-15, 2016 Brisbane, Australia; Cardiovascular Medicine Conference August 01-02, 2016 Manchester, UK; Global Cardiologists  Meeting July 18-20, 2016 Berlin, Germany; Echocardiography Conference July 18-19, 2016 Berlin, Germany; International Cardiac Conference September 14-15, 2016 Philadelphia, USA; World Cardiothoracic Meeting December 08-09, 2016 Philadelphia, USA. 19th Annual Update on Pediatric and Congenital Cardiovascular Disease February 24- 28, 2016, Orlando, USA; American Cardiology Congress 2016; ACC Annual Meeting 2016; American Cardiology Congress 2016; European Cardiology Congress August 27-31, 2016 Rome, Italy; 21st World Congress on Heart Disease, July 30-August 01, 2016, Boston, MA, USA; 5th Annual Innovations in Valve and Structural Heart disease 2016, Feb 15-17 One Baha Mar Boulevard, Nassau, Bahamas; International Conference on Cardiology and Cardiac surgery April 04-06, 2016, Dubai, UAE

 

Track 7: Plaque & Virus-induced atherosclerosis

Atherosclerosis often develops at branch points or curving portions along extracranial and intracranial large arteries, locations where blood flow is slowed and more turbulent. The internal carotid artery is particularly at risk. Exactly where disease tends to occur, though, and how quickly it progresses apparently reflect the individual's genetic background. With time, such an accumulation can form an elevated plaque that protrudes into the vessel's lumen and significantly reduces blood flow. 

Viruses contribute to the pathogenesis of atherosclerosis either via direct infection of vascular cells or via the indirect effects of cytokines or acute phase proteins induced by infection at non-vascular sites. There are now a large number of different infectious agents that are linked with an increased risk of cardiovascular disease.

Related Conferences: Arrhythmia and Cardiac Surgery Meeting July 14-15, 2016 Brisbane, Australia; Cardiovascular Medicine Conference August 01-02, 2016 Manchester, UK; Global Cardiologists  Meeting July 18-20, 2016 Berlin, Germany; Echocardiography Conference July 18-19, 2016 Berlin, Germany; International Cardiac Conference September 14-15, 2016 Philadelphia, USA; World Cardiothoracic Meeting December 08-09, 2016 Philadelphia, USA. 19th Annual Update on Pediatric and Congenital Cardiovascular Disease February 24- 28, 2016, Orlando, USA; American Cardiology Congress 2016; ACC Annual Meeting 2016; American Cardiology Congress 2016; European Cardiology Congress August 27-31, 2016 Rome, Italy; 21st World Congress on Heart Disease, July 30-August 01, 2016, Boston, MA, USA; 5th Annual Innovations in Valve and Structural Heart disease 2016, Feb 15-17 One Baha Mar Boulevard, Nassau, Bahamas; International Conference on Cardiology and Cardiac surgery April 04-06, 2016, Dubai, UAE

 

Track 8: Atherosclerosis – Gender Difference

Cardiovascular disease develops 7 to 10 years later in women than in men and is still the major cause of death in women. The under-recognition of heart disease and differences in clinical presentation in women lead to less aggressive treatment strategies and a lower representation of women in clinical trials. Furthermore, self-awareness in women and identification of their cardiovascular risk factors needs more attention, which should result in a better prevention of cardiovascular events. It is assumed that exposure to endogenous oestrogens during the fertile period of life delays the manifestation of atherosclerotic disease in women. Although studies have shown that hormonal dysfunction in premenopausal women is associated with an increased risk of atherosclerosis and CHD events, it is still unclear whether the polycystic ovary syndrome (PCOS) is an independent risk factor for atherosclerosis.

Related Conferences: Arrhythmias Congress July 14-15, 2016 Brisbane, Australia; Cardio Vascular Medicine Conference August 01-02, 2016 Manchester, UK; International Cardiac Conference September 14-15, 2016 Philadelphia, USA; Echocardiography Conference June 06-07, 2016 London, UK; World Congress of Cardiology and Cardiovascular Health Mexico City, Mexico June 04-07, 2016; American Cardiology Association, 2016; ACC Annual Meetings, 2016; 19th Annual Update on Paediatric and Congenital Cardiovascular Disease February 24- 28, 2016, Orlando; European Society of Cardiology Congress 27-31 August 2016 Rome, Italy; European Cardiology Congress, 2016; 4th International Conference on Prehypertension, Hypertension & Cardio Metabolic Syndrome, March 03-06, 2016, Venice, Italy; Cardiac Society of Cardiology, 2016
 

Track 9: Lipoproteins and Lipid Transport

The plasma lipoproteins are the primary means of transport of cholesterol among tissues. In particular, the apo B-containing lipoproteins (VLDL, IDL and LDL) are important for the delivery of cholesterol from the liver to peripheral tissues, while HDL appear to mediate the reverse process of movement of cholesterol from tissues back to the liver. Both of these transport processes are necessary for efficient whole body cholesterol homeostasis, because the liver is the major site of both the production and excretion of cholesterol. However, deviations from a proper balance of transport of cholesterol, either increases in LDL levels or decreases in HDL cholesterol flux, may result in accumulation of cholesterol in extra hepatic tissues. Increased risk of atherosclerosis and CHD may be associated with elevation in the number of LDL particles, increase or decrease in LDL particle size, or changes in the composition of plasma LDL.

Related Conferences: Arrhythmia and Cardiac Surgery Meeting July 14-15, 2016 Brisbane, Australia; Cardiovascular Medicine Conference August 01-02, 2016 Manchester, UK; Global Cardiologists  Meeting July 18-20, 2016 Berlin, Germany; Echocardiography Conference July 18-19, 2016 Berlin, Germany; International Cardiac Conference September 14-15, 2016 Philadelphia, USA; World Cardiothoracic Meeting December 08-09, 2016 Philadelphia, USA. 19th Annual Update on Pediatric and Congenital Cardiovascular Disease February 24- 28, 2016, Orlando, USA; American Cardiology Congress 2016; ACC Annual Meeting 2016; American Cardiology Congress 2016; European Cardiology Congress August 27-31, 2016 Rome, Italy; 21st World Congress on Heart Disease, July 30-August 01, 2016, Boston, MA, USA; 5th Annual Innovations in Valve and Structural Heart disease 2016, Feb 15-17 One Baha Mar Boulevard, Nassau, Bahamas; International Conference on Cardiology and Cardiac surgery April 04-06, 2016, Dubai, UAE
 

 

Track 10: Hypertension

Hypertension is a common condition in which the long-term force of the blood against your artery walls is high enough that it may eventually cause health problems, such as heart disease. Blood pressure is determined both by the amount of blood your heart pumps and the amount of resistance to blood flow in your arteries. The more blood your heart pumps and the narrower your arteries, the higher your blood pressure. In most people with established essential hypertension, increased resistance to blood flow accounts for the high pressure while cardiac output remains normal.

Related Conferences: Arrhythmias Congress July 14-15, 2016 Brisbane, Australia; Cardio Vascular Medicine Conference August 01-02, 2016 Manchester, UK; International Cardiac Conference September 14-15, 2016 Philadelphia, USA; Echocardiography Conference June 06-07, 2016 London, UK; World Congress of Cardiology and Cardiovascular Health Mexico City, Mexico June 04-07, 2016; American Cardiology Association, 2016; 19th Annual Update on Pediatric and Congenital Cardiovascular Disease February 24- 28, 2016, Orlando; European Society of Cardiology Congress 27-31 August 2016 Rome, Italy; European Cardiology Congress, 2016; 4th International Conference on Prehypertension, Hypertension & Cardio Metabolic Syndrome, March 03-06, 2016, Venice, Italy; Cardiac Society of Cardiology, 2016; World Cardiology Congress, 2016
 

Track 11: Atherosclerosis Therapeutics

Treatments for atherosclerosis may include heart-healthy lifestyle changes, medicines, and medical procedures or surgery includes, lowering the risk of blood clots forming, preventing atherosclerosis-related diseases, reducing risk factors in an effort to slow or stop the build-up of plaque, relieving symptoms and widening or bypassing plaque-clogged arteries.

Related Conferences: Arrhythmia and Cardiac Surgery Meeting July 14-15, 2016 Brisbane, Australia; Cardiovascular Medicine Conference August 01-02, 2016 Manchester, UK; Global Cardiologists  Meeting July 18-20, 2016 Berlin, Germany; Echocardiography Conference July 18-19, 2016 Berlin, Germany; International Cardiac Conference September 14-15, 2016 Philadelphia, USA; World Cardiothoracic Meeting December 08-09, 2016 Philadelphia, USA. 19th Annual Update on Pediatric and Congenital Cardiovascular Disease February 24- 28, 2016, Orlando, USA; American Cardiology Congress 2016; ACC Annual Meeting 2016; American Cardiology Congress 2016; European Cardiology Congress August 27-31, 2016 Rome, Italy; 21st World Congress on Heart Disease, July 30-August 01, 2016, Boston, MA, USA; 5th Annual Innovations in Valve and Structural Heart disease 2016, Feb 15-17 One Baha Mar Boulevard, Nassau, Bahamas; International Conference on Cardiology and Cardiac surgery April 04-06, 2016, Dubai, UAE
 

 

Track 12: Clinical Trials in Cardiology

Clinical trials in cardiology research investigations are being conducted in which people of cardiac failures or disorders volunteer to test new treatments, interventions or tests as a means to prevent, detect, treat or manage various cardiovascular diseases or medical conditions. Some investigations look at how people respond to a new intervention and the side effects which might occur. This helps to determine if a new intervention works, if it is safe, and if it is better than the interventions that are already available. Clinical trials might also compare existing interventions, test new ways to use or combine existing interventions or observe how people respond to other factors that might affect their health such as dietary changes.

Related Conferences: Arrhythmias Congress July 14-15, 2016 Brisbane, Australia; Cardio Vascular Medicine Conference August 01-02, 2016 Manchester, UK; International Cardiac Conference September 14-15, 2016 Philadelphia, USA; Echocardiography Conference June 06-07, 2016 London, UK; World Congress of Cardiology and Cardiovascular Health Mexico City, Mexico June 04-07, 2016; American Cardiology Association, 2016; 19th Annual Update on Pediatric and Congenital Cardiovascular Disease February 24- 28, 2016, Orlando; European Society of Cardiology Congress 27-31 August 2016 Rome, Italy; European Cardiology Congress, 2016; 4th International Conference on Prehypertension, Hypertension & Cardio Metabolic Syndrome, March 03-06, 2016, Venice, Italy; Cardiac Society of Cardiology, 2016; World Cardiology Congress, 2016
 

Track 13: Atherosclerosis On-going Research

In the battle against atherosclerosis, the stakes remain high. Atherosclerosis involves inflammation and build-up of fatty plaques, or atheroma within vessel walls, which eventually lead to the hardening and narrowing of the arteries. When an atheroma ruptures, a blood clot can form to trigger a heart attack or stroke.

Because development of atherosclerosis in the body is a complex process, researchers are labouring on many fronts to find new ways to understand and treat this serious disease.

Related Conferences:  Arrhythmia and Cardiac Surgery Meeting July 14-15, 2016 Brisbane, Australia; Cardiovascular Medicine Conference August 01-02, 2016 Manchester, UK; Global Cardiologists  Meeting July 18-20, 2016 Berlin, Germany; Echocardiography Conference July 18-19, 2016 Berlin, Germany; International Cardiac Conference September 14-15, 2016 Philadelphia, USA; World Cardiothoracic Meeting December 08-09, 2016 Philadelphia, USA. 19th Annual Update on Pediatric and Congenital Cardiovascular Disease February 24- 28, 2016, Orlando, USA; American Cardiology Congress 2016; ACC Annual Meeting 2016; American Cardiology Congress 2016; European Cardiology Congress August 27-31, 2016 Rome, Italy; 21st World Congress on Heart Disease, July 30-August 01, 2016, Boston, MA, USA; 5th Annual Innovations in Valve and Structural Heart disease 2016, Feb 15-17 One Baha Mar Boulevard, Nassau, Bahamas; International Conference on Cardiology and Cardiac surgery April 04-06, 2016, Dubai, UAE
 

 

Track 14: Pediatric Cardiology

Pediatric Cardiology is responsible for the diagnosis of congenital heart defects, performing diagnostic procedures such as echocardiograms, cardiac catheterizations and electrophysiology studies. The increasing number of neonates with congenital heart defects referred to the neonatal intensive care unit reflects the increasing awareness that the defects may be present. Chest radiography and ECG rarely assist in the neonatal diagnosis. Congestive heart failure in the fetus, or hydrops, can be detected by performing fetal echocardiography. Many of the pediatric heart defects such as patent ductus arteriosus interruption, vascular ring division, pericardial window, diaphragm placation, thoracic duct ligation, ligation of collateral vessels have been repaired using pediatric interventional cardiology. Apart from these techniques nursing and care for pediatric cardiac patients also plays an important role for the cure of pediatric cardiac patients.

Related Conferences: Arrhythmias Congress July 14-15, 2016 Brisbane, Australia; Cardio Vascular Medicine Conference August 01-02, 2016 Manchester, UK; International Cardiac Conference September 14-15, 2016 Philadelphia, USA; Echocardiography Conference June 06-07, 2016 London, UK; World Congress of Cardiology and Cardiovascular Health Mexico City, Mexico June 04-07, 2016; American Cardiology Association, 2016; 19th Annual Update on Pediatric and Congenital Cardiovascular Disease February 24- 28, 2016, Orlando; European Society of Cardiology Congress 27-31 August 2016 Rome, Italy; European Cardiology Congress, 2016; 4th International Conference on Prehypertension, Hypertension & Cardio Metabolic Syndrome, March 03-06, 2016, Venice, Italy; Cardiac Society of Cardiology, 2016; World Cardiology Congress, 2016
 

Track 15: Advances in Cardiology Education

Advances in Cardiology Education represent the current thinking of international experts regarding the underlying mechanisms of cardiovascular risk and the pathogenesis & pathophysiology of heart and its related disorders. This session gives new insights into the relationship between arterial stiffness, cardiovascular diagnosis, vascular study and atherosclerosis, but also establishes the possible interactions with age and other cardiovascular factors such as high blood pressure, diabetes and hyperlipidemia.

Related Conferences: Arrhythmia and Cardiac Surgery Meeting July 14-15, 2016 Brisbane, Australia; Cardiovascular Medicine Conference August 01-02, 2016 Manchester, UK; Global Cardiologists  Meeting July 18-20, 2016 Berlin, Germany; Echocardiography Conference July 18-19, 2016 Berlin, Germany; International Cardiac Conference September 14-15, 2016 Philadelphia, USA; World Cardiothoracic Meeting December 08-09, 2016 Philadelphia, USA. 19th Annual Update on Pediatric and Congenital Cardiovascular Disease February 24- 28, 2016, Orlando, USA; American Cardiology Congress 2016; ACC Annual Meeting 2016; American Cardiology Congress 2016; European Cardiology Congress August 27-31, 2016 Rome, Italy; 21st World Congress on Heart Disease, July 30-August 01, 2016, Boston, MA, USA; 5th Annual Innovations in Valve and Structural Heart disease 2016, Feb 15-17 One Baha Mar Boulevard, Nassau, Bahamas; International Conference on Cardiology and Cardiac surgery April 04-06, 2016, Dubai, UAE
 

 

Track 16: Entrepreneur Investment Meet

For sustaining India's rapid economic growth entrepreneurship is the counteractant. Entrepreneur is an individual who, rather than working as an employee, runs a small business and assumes all the risk and reward of a given business venture, idea, or good or service offered for sale. The present conference creates a global platform to interact Entrepreneurs and the Investors globally in the field of cardiology and cardiovascular diseases control, which is going to lead a healthy life ultimately to healthy world.

Related Conferences: Arrhythmias Congress July 14-15, 2016 Brisbane, Australia; Cardio Vascular Medicine Conference August 01-02, 2016 Manchester, UK; International Cardiac Conference September 14-15, 2016 Philadelphia, USA; Echocardiography Conference June 06-07, 2016 London, UK; World Congress of Cardiology and Cardiovascular Health Mexico City, Mexico June 04-07, 2016; American Cardiology Association, 2016; 19th Annual Update on Paediatric and Congenital Cardiovascular Disease February 24- 28, 2016, Orlando; European Society of Cardiology Congress 27-31 August 2016 Rome, Italy; European Cardiology Congress, 2016; 4th International Conference on Prehypertension, Hypertension & Cardio Metabolic Syndrome, March 03-06, 2016, Venice, Italy; Cardiac Society of Cardiology, 2016; World Cardiology Congress, 2016
 

Track 17: Exemplification of Patients 

Atherosclerosis remains a major cause of death in industrialized countries. In vivo visualization of the atherosclerotic plaque and its components (calcifications, fibro cellular tissue, lipid core, hemorrhage, and thrombus), particularly in humans, will further elucidate the disease process and the effect of various types of interventions, and subsequently will have important clinical implications. Recently, angiography and ultrasound were the most common methods of analyzing atherosclerotic disease. Angiography provides information on the degree of stenosis but only limited information on the morphology of the atherosclerotic plaque. Ultrasound is able to visualize the plaque and to demonstrate the presence of calcifications.

Related Conferences: Arrhythmia and Cardiac Surgery Meeting July 14-15, 2016 Brisbane, Australia; Cardiovascular Medicine Conference August 01-02, 2016 Manchester, UK; Global Cardiologists  Meeting July 18-20, 2016 Berlin, Germany; Echocardiography Conference July 18-19, 2016 Berlin, Germany; International Cardiac Conference September 14-15, 2016 Philadelphia, USA; World Cardiothoracic Meeting December 08-09, 2016 Philadelphia, USA. 19th Annual Update on Pediatric and Congenital Cardiovascular Disease February 24- 28, 2016, Orlando, USA; American Cardiology Congress 2016; ACC Annual Meeting 2016; American Cardiology Congress 2016; European Cardiology Congress August 27-31, 2016 Rome, Italy; 21st World Congress on Heart Disease, July 30-August 01, 2016, Boston, MA, USA; 5th Annual Innovations in Valve and Structural Heart disease 2016, Feb 15-17 One Baha Mar Boulevard, Nassau, Bahamas; International Conference on Cardiology and Cardiac surgery April 04-06, 2016, Dubai, UAE

Atherosclerotic cardiovascular disease is the leading cause of mortality worldwide. The epidemiology of coronary heart disease is extensive and remains the leading cause of death in both men and women. Atherosclerosis is a disease in which plaque builds up inside arteries, blood vessels that carry oxygen-rich blood to heart and other parts of body. Plaque is made up of fat, cholesterol, calcium, and other substances found in the blood. Over time, plaque hardens and narrows arteries. This limits the flow of oxygen-rich blood to your organs and other parts of your body. Atherosclerosis can affect any artery in the body, including arteries in the heart, brain, arms, legs, pelvis, and kidneys. As a result, different diseases may develop based on which arteries are affected. Atherosclerosis sometimes called hardening of the arteries which can slowly narrow and harden the arteries throughout the body. When atherosclerosis affects the arteries of the heart, it’s called coronary artery disease.

The committee of Annual Conference on Atherosclerosis and Clinical Cardiology which is to be held during July  11-12, 2016 at Philadelphia, USA promises to showcase the top-notch research work on atherosclerosis which is one of the root cause for the heart failure and low functioning of the heart. This conference will bring together world-class professors, scientists and cardiologists to discuss strategies for disease remediation for heart in this cardiology conference. The conference is focalize on topics like clinical cardiology, coronary artery atherosclerosis, atherosclerosis risk factors, atherosclerosis aneurysm, lipoproteins and lipid transport, atherosclerosis therapeutics, hypertension, plaque hardens and narrows arteries  and many more…

The Atherosclerosis 2016 will be organized around the theme “Advancements in management of Atherosclerosis ".

Annual Conference on Atherosclerosis and Clinical Cardiology
 
July 11-12, 2016 Philadelphia, USA
 
Theme: Advancements in managements of Atherosclerosis
 
Atherosclerosis is a specific form of arteriosclerosis in which an artery wall thickens as a result of invasion and accumulation of white blood cells (WBCs) (foam cell) and proliferation of intimal smooth muscle cell creating a fibro fatty plaque. Atherosclerosis is asymptomatic for decades because the arteries enlarge at all plaque locations, thus there is no effect on blood flow. Even most plaque ruptures do not produce symptoms until enough narrowing or closure of an artery, due to clots, occurs.
 
Scope and Importance:
 
In 2010, cardiovascular, lung, and blood diseases accounted for 1,017,000 deaths and 41 % of all deaths in the United States. The estimated economic cost in 2009 for these diseases was $424 billion 23 % of the total economic costs of illness, injuries, and death. Of all diseases, heart disease is the leading cause of death; chronic lower respiratory diseases (CLRD), which includes COPD and asthma, ranks third (behind cancer); and cerebrovascular disease is fourth. Cardiovascular and lung diseases account for 3 of the 4 leading causes of death and 4 of the 10 leading causes of infant death. Hypertension, asthma, CHD, and COPD are especially prevalent and account for substantial morbidity in Americans.
 
Why it’s in Philadelphia, USA?
 
In the United States and most other developed countries, atherosclerosis is the leading cause of illness and death. Estimates for last few years in the United States alone are that about 16 million people have atherosclerotic heart disease and 5.8 million have stroke. Cardiovascular disease, primarily coronary and cerebrovascular atherosclerosis, caused almost 812,000 deaths, more than cancer caused and 7 times as many as injuries caused. This year an estimated 1.2 million Americans will have a heart attack. Despite significant medical advances, heart attacks due to coronary artery disease (atherosclerosis that affects the arteries supplying blood to the heart and stroke are responsible for more deaths than all other causes combined.
 
Why to attend???
 
With members from around the world focused on learning about Cardiology and cardiovascular diseases, this is your single best opportunity to reach the largest assemblage of participants from the hospitals, universities, and organizations etc. This Annual Meeting will conduct demonstrations, distribute information, meet with current and potential researchers and receive name recognition at this event. World-renowned speakers, the most recent techniques, and the newest updates in this field are signet of this conference.
 
Cardiology's 10 Greatest Discoveries of the 20th Century:
 
Echocardiography
Preventive Cardiology and the Framingham Study
Lipid Hypotheses and Atherosclerosis
Coronary Care Units
Echocardiography
Thrombolytic Therapy
Cardiac Catheterization and Coronary Angiography
Open-Heart Surgery
Automatic Implantable Cardiac Defibrillators
Coronary Angioplasty
 
Universities/Organizations Associated with Atherosclerosis Research: 
 
In Philadelphia
 
Penn Cardiovascular Institute 
Strayer University, Bensalem, Pennsylvania 
Swarthmore College, Swarthmore, Pennsylvania 
Temple University School of Medicine, Philadelphia
University of Pennsylvania 
Valley Forge Christian College, Phoenixville, Pennsylvania  
 
In USA
 
CATO Research, Durham, North California, USA
Columbia University College, New York
The Rockefeller University, New York
University of Iowa Carver College of Medicine, Iowa City
University of Kentucky College of Medicine, Lexington KY, USA
 
Globally  
 
National University, Singapore
Oregon State University 
Robarts Research Institute, London
The Scandinavian Society for Atherosclerosis Research (SSAR), Copenhagen
The Thrombosis & Atherosclerosis Research Institute (TaARI), Ontario
The University of Glasgow, Scotland, UK
The University of Sydney, Australia
The University of Vermont, Burlington
University of California, San Francisco
University of Colorado Boulder
University of Manitoba, Winnipeg, Canada 
University of Maryland Medical Centre, Baltimore
University of Minnesota, Minneapolis 
University of Nevada, Reno
University of Southern California, Los Angeles
 
Statistics of Cardiovascular Diseases & Atherosclerosis:
 
More than 787,000 people in the U.S. died from heart disease, stroke and other cardiovascular diseases in 2010. That’s about one of every three deaths in America. About 2,150 Americans die each day from these diseases, one every 40 seconds. Cardiovascular diseases claim more lives than all forms of cancer combined. About 83.6 million Americans are living with some form of cardiovascular disease or the after-effects of stroke. Direct and indirect costs of cardiovascular diseases and stroke total more than $315.4 billion. That includes health expenditures and lost productivity. Nearly half of all African-American adults have some form of cardiovascular disease, 49 % of women and 44 % of men. Heart disease is the No. 1 cause of death in the world and the leading cause of death in the United States, killing almost 380,000 Americans a year. Heart disease accounts for 1 in 6 deaths in the U.S. Someone in the U.S. dies from heart disease about once every 90 seconds.
 
Market Growth of Atherosclerosis Research in the last and upcoming ten years:
 
Heart disease affects whites and African Americans the most, accounting for 24.3 and 24.1 % of deaths, respectively. Asians and Pacific Islanders are at third-highest risk for a heart disease-related death, at 22.5 %. It accounts for 20.8 % of deaths in the Hispanic community, and 17.9 % in American Indians and Alaska Natives.
 
 
Industries Globally for Cardiovascular & Atherosclerosis Research:
 
AstraZeneca
Care stream Health
GlaxoSmithKline
Intelomed
Keystone Medical Technologies
Sanofi
 
The top five countries with the lowest rates of heart disease deaths:  
 
France
Australia
Switzerland
Japan
Israel
 
 
Advanced Atherosclerosis Techniques:
 
Balloon angioplasty
Coronary artery stenting
Excimer laser angioplasty
Intracoronary ultrasound
Rotational, directional and trans luminal extraction atherectomy
 
Products manufactured by the industry related to Cardiology & Cardiovascular Diseases Research Globally:
 
Pacemakers
Implantable defibrillators Stents 
Remote Patient Management.
Vascular/Surgical Devices
Small Molecules
Heart valve corrective device & Stents 
Specialized medicines
Medical Diagnostic Instruments
Single-use cardiovascular medical devices
 
Cardiovascular Market Research Reports & Industry Analysis:
 
Cardiovascular conditions can include angina, arrhythmia, atherosclerosis, congestive heart failure, coronary artery disease, hypertension, myocardial infarction or other disorders. All these diseases involve a malfunction of the heart or related circulatory system. Variations in heart size and position within the chest may be related to age, body size, shape, weight, or pathologic conditions of the heart and other nearby structures. There has been considerable study into the role of inflammation in heart disease. Researchers have found the first direct evidence that reducing inflammation in coronary arteries decreases the risk of heart attacks as much as reducing cholesterol levels. New drugs that target inflammation that are measured by a marker called C-reactive protein (CRP) could have a large impact on cardiovascular health as well as a large financial gain for companies developing these products.
 
Risk Prediction for Global CVD:
 
Whereas CHD is a major component of overall CVD, it does not include other important manifestations such as stroke, heart failure, and peripheral arterial disease. Framingham investigators have considered that for risk functions, a broader class of CVD components would be appropriate, especially for public health. In line with this in 2008, Framingham investigators presented a global CVD risk function for estimating the risk of developing any manifestations of CVD (including CHD, cerebrovascular disease, intermittent claudication, and congestive heart failure). The global CVD function produces an absolute risk estimate for global CVD and, by simple adjustments, the risk for any of the components of CVD. As an example, for a woman age 61 years, with HDL of 47, total cholesterol of 230, non-treated systolic blood pressure of 124, and who are a non-smoker and non-diabetic, the corresponding points are 9, 0, 3, 0, and 0 for a total of 12 points, which corresponds to a 10-year risk of CVD of 8.6%. For comparison, the ATP III function produces for this woman a 10-year risk of developing a hard CHD of 3%.
 
Fund Allotment to Atherosclerosis Research:
 
One hundred and forty-nine investigators working in the cardiovascular field have been awarded grants-in-aid under the research support program of the Association and its affiliates. The grants brought to 260 the number of research awards made by the Association this year. Previously announced were 111 investigator ship and fellowship awards. The grants have a total value of $723,972.45. In all, the National Office has awarded $1, 418, - 972.45 for research support, nearly 50 % more than the $990,056 allotted last year. The overall total of research support by Heart Associations since the A.H.A. became a national voluntary health agency in 1948 is now close to the $11-million mark.
Cardiology-2015

In the presence of inter professional researchers and practitioners involved in the development of high quality education in all aspects of clinical skills, OMICS 5th International Conference on Clinical & Experimental Cardiology was held during April 27-29, 2015 in Philadelphia, USA

OMICS Group played host to a diverse panel of key members of the Cardiology community from research lab, industry, academia and financial investment practices, discussing the future of Cardiology specialties. This event was really aimed for examining where the real cardiological specialties are going in the future and purpose of the event was to provide an opportunity for cross fertilization of ideas and development of ideas, in the field of Cardiology.

Focusing on Heart Diseases, Congenital Heart Diseases, Cardiac Therapeutic Agents, Biophysics and Systems Biology, Interventional Cardiology, Cancer and Heart, Current Research in Cardiology and Cardiac Surgery as well, the three days of discussions enabled professionals to gain an insight into the current innovations and opened up networking opportunities.

Cardiology-2015 Organizing Committee would like to thank the Moderators of the conference, Dr. Anastasia Susie Mihailidou, Royal North Shore Hospital & Kolling Institute, Australia and Dr. Mahazarin Ginwalla, University Hospitals Case Medical Center, USA who contributed a lot for the smooth functioning of this event.

We are also thank full to all the speakers who made this event a grand success, our special thanks to Stacy Masucci, Elsevier and Dr. John E. Strobeck, Daxor Corporation  for exhibiting at the conference, many thanks to all the media partners for the promotion of our event.

The highlights of the meeting were the eponymous lectures, delivered by Louis Samuels from Thomas Jefferson University School of Medicine, The Lankenau Heart Institute, USA, Anthony Martin Gerdes from New York Institute of Technology-College of Osteopathic Medicine, USA, Kate M Denton from Monash University, Australia, Yoshiaki Omura from New York Medical College, Heart Disease Research Foundation, USA, Robert M Mentzer from Wayne State University School of Medicine, USA, Karlheinz Seidl from Klinikum Ingolstadt GmbH, Germany. These talks were of great interest to the general cardiologists and were enormously informative.

OMICS 5th International Conference on Clinical & Experimental Cardiology was a great success with the support of international, multiprofessional steering committee and coordinated by the Journal of Clinical & Experimental Cardiology, Journal of Cardiovascular Diseases & Diagnosis and Cardiovascular Pharmacology: Open Access.


Past Reports  Proceedings  Gallery  

Cardiology-2014

In the presence of inter professional researchers and practitioners involved in the development of high quality education in all aspects of clinical skills, OMICS 4th International Conference on Clinical & Experimental Cardiology was held during April 14-16, 2014 in San Antonio, USA

OMICS Group played host to a diverse panel of key members of the Cardiology community from research lab, industry, academia and financial investment practices, discussing the future of Cardiology specialties. This event was really aimed for examining where the real cardio logical specialties are going in the future and purpose of the event was to provide an opportunity for cross fertilization of ideas and development of ideas, in the field of Cardiology.

Focusing on Heart Diseases, Congenital Heart Diseases, Cardiac Therapeutic Agents, Biophysics and Systems Biology, Interventional Cardiology, Cancer and Heart, Current Research in Cardiology, and Cardiac Surgery as well, the three days of discussions enabled professionals to gain an insight into the current innovations and opened up networking opportunities.

Cardiology-2014 Organizing Committee would like to thank the Moderator of the conference, Dr. Anastasia Susie Mihailidou, Royal North Shore Hospital, Australia who contributed a lot for the smooth functioning of this event.

The highlights of the meeting were the eponymous lectures, delivered by Louis Samuels, Thomas Jefferson University School of Medicine, USA, Richard J. Frink, Heart Research Foundation of Sacramento, USA, Bradley Field Bale, Bale/Doneen Method, USA, Karlheinz Seidl, Klinikum Ingolstadt, Germany. These talks were of great interest to the general cardiologists and were enormously informative.

OMICS 4th International Conference on Clinical & Experimental Cardiology was a great success with the support of international, multiprofessional steering committee and coordinated by the Journal of Clinical & Experimental Cardiology, Journal of Cardiovascular Diseases & Diagnosis.


Past Reports  Gallery  

Cardiology-2013

3rd International Conference on Clinical & Experimental Cardiology (Cardiology -2013) held during April 15-17, 2013 at Chicago/Northbrook, USA, was a dynamic forum for all cardiologists, healthcare professionals, scientists and medical executives from around the world who are actively involved in patient care, research, therapeutics development including basic, translational, and clinical aspects, epidemiology, prevention, diagnosis, and drug discovery and development. The conference provided participants a platform to exchange ideas, and to share breakthroughs and promising solutions to the most important issues in the field.

The day featured formal presentations from key researchers as well as time for questions and informal discussion. The theme of the conference was “Emerging interventions in clinical cardiology and cardiac surgery”.

Keynote sessions were delivered by great speakers, Louis E Samuels, Lankenau Medical Center, USA, Vincent DOR, Centre Cardiothoracique de Monaco, Monaco Cedex, Richard J Frink, Heart Research Foundation of Sacramento, USA, Ming K Heng, University of California, USA. They made excellent presentations and their experiences gained inside/outside the lab were warmly discussed with the audiences at the keynote forum.

The conference was chaired by Xiaoping Ren, James D Fett, Ming k heng, Emad Aziz, Samuel C. Dudley, Anthony Ashton, Alexander D. Verin, Anastasia Susie Mihailidou, JanGlatz, Mentzer, Dr. Ramin Artang, Louis Samuels, and Geetha Bhat.

During the conference, a workshop was introduced by Jozsef Pal Vas and Noemi Csaszar, Hungarian Association of Hypnosis, Hungary. The title for the workshop was “Tandem hypnotherapy (THT) as a new method functioned at sensori-motor level”.
Along with the participants of Cardiology Conference, we would like to express our gratitude to Mr. Frank King, The Cardiac Comedian, for his special appearance at the conference.


Past Reports  Gallery  

Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date July 11-12, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Day 1 Day 2
Poster Opportunity Available

Media Partners

Conferenceseries Destinations